Glucocorticoid Receptor Activation Reprograms NK Cells to Drive AREG-Mediated Immunosuppression: A Pan-Cancer Role

Qin Wei1, Guirong Liang1, Rui Zeng1

  • 1Jiangsu Provincial Key Laboratory of Dermatology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, 210042, China.

Insights

Natural killer (NK) cells combat tumors but are suppressed in the tumor microenvironment. Glucocorticoid receptor (GR) activation drives amphiregulin (AREG) production, impairing NK cell anti-tumor activity and offering a therapeutic target.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Natural killer (NK) cells are crucial for anti-tumor immunity.
  • Tumor microenvironments often induce immunosuppression, impairing NK cell function.
  • Cutaneous malignancies exhibit NK cell dysfunction characterized by reduced IFN-γ/TNF-α and increased amphiregulin (AREG).

Purpose of the Study:

  • To investigate the molecular mechanisms of NK cell dysfunction in cutaneous malignancies.
  • To identify the role of the glucocorticoid receptor (GR/NR3C1) pathway in reprogramming tumor-associated NK cells.
  • To evaluate the therapeutic potential of targeting the GR-AREG axis.

Main Methods:

  • Single-cell transcriptomic analysis of tumor-infiltrating NK cells.
  • Functional validation of glucocorticoid and prostaglandin E2 (PGE2) effects on NK cells.
  • Genetic ablation and pharmacological inhibition of NR3C1.
  • Assessment of AREG's impact on NK cell-mediated apoptosis.
  • Adoptive transfer of AREG-deficient NK cells in mouse models.

Main Results:

  • Elevated GR/NR3C1 pathway activity correlates with NK cell reprogramming.
  • Glucocorticoids induce AREG production in NK cells, augmented by PGE2.
  • NR3C1 inhibition blocks glucocorticoid-driven AREG induction.
  • GR activation leads to persistent chromatin accessibility at the AREG locus.
  • AREG production impairs NK cell anti-tumor apoptosis; AREG-deficient NK cells suppress tumor growth.

Conclusions:

  • The GR-AREG axis is a key mechanism of NK cell suppression in cancer.
  • Targeting GR or AREG can restore NK cell anti-tumor functions.
  • This axis represents a promising multi-layered therapeutic strategy for enhancing anti-cancer immunity.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.6K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
7.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K